A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder - Conley, Robert R.; Mahmoud, Ramy (The American journal of psychiatry, 2001)
Keywords: Adult; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Basal Ganglia Diseases - chemically induced; Basal Ganglia Diseases - epidemiology; Benzodiazepines; Biological and medical sciences; Clinical trials; Double blind randomized trials; Double-Blind Method; Drug Administration Schedule; Drug therapy; Female; Humans; Male; Medical sciences; Neuropharmacology; Olanzapine; Pharmacology. Drug treatments; Pirenzepine - adverse effects; Pirenzepine - analogs & derivatives; Pirenzepine - therapeutic use; Psychiatric Status Rating Scales - statistics & numerical data; Psychiatry; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Psychotic Disorders - diagnosis; Psychotic Disorders - drug therapy; Psychotic Disorders - psychology; Risperidone; Risperidone - adverse effects; Risperidone - therapeutic use; Safety; Schizoaffective disorder; Schizophrenia; Schizophrenia - diagnosis; Schizophrenia - drug therapy; Schizophrenic Psychology; Treatment Outcome; Weight Gain - drug effects; Human; Schizoaffective psychosis; Olanzapine; Neuroleptic; Psychotropic; Dopamine receptor; Toxicity; Dopamine antagonist; Serotonin antagonist; Treatment efficiency; Schizophrenia; Serotonine receptor; Dose activity relation; Psychosis; Chemotherapy; Treatment; Follow up study; Atypical; Antagonist; Risperidone; Comparative study